Spironolactone vs Oseltamivir: side-by-side comparison
Spironolactone (Potassium-sparing diuretic / aldosterone antagonist) and Oseltamivir (Neuraminidase inhibitor) belong to different therapeutic classes and are rarely substitutes for each other. The comparison is useful when a single patient is weighing both options for adjacent or overlapping needs.
| Property | Spironolactone | Oseltamivir |
|---|---|---|
| Therapeutic class | Potassium-sparing diuretic / aldosterone antagonist | Neuraminidase inhibitor |
| CAS | 52-01-7 | 196618-13-0 |
| ATC | C03DA01 | J05AH02 |
| Molecular weight | 416.57 g/mol | 312.40 g/mol |
| Brands with this active ingredient | 1 | 1 |
What they share
Spironolactone and Oseltamivir share the common regulatory framework for prescription active ingredients, bioequivalence standards for generics, and pharmacist oversight. Beyond that, points in common are limited.
Key differences
Spironolactone acts by a different mechanism than Oseltamivir, with indications that barely overlap. Comparing the two is useful when a clinician has mentioned both in the same context or the patient wants to understand why one was prescribed instead of the other.
Mechanisms compared
Spironolactone: Spironolactone competitively blocks the mineralocorticoid (aldosterone) receptor in the distal tubule of the kidney, reducing sodium reabsorption and potassium excretion. Oseltamivir: Oseltamivir is a prodrug rapidly hydrolysed by hepatic esterases to the active metabolite oseltamivir carboxylate, which selectively inhibits the neuraminidase enzyme on the surface of influenza A and B viruses.
Indications compared
Spironolactone: Spironolactone is approved for heart failure with reduced ejection fraction, primary hyperaldosteronism, resistant hypertension, oedema in cirrhosis or nephrotic syndrome, and certain potassium-loss states. Oseltamivir: Oseltamivir is approved in adults and children for the treatment of acute uncomplicated influenza A and B when started within 48 hours of symptom onset, and for post-exposure prophylaxis of influenza A and B in patients…
Safety profile
Spironolactone: Common adverse effects include hyperkalaemia (especially with renal impairment or ACE inhibitors), gynaecomastia in men, menstrual irregularities in women, and dizziness from blood pressure effects. Oseltamivir: Common adverse effects include nausea and vomiting, particularly when taken without food.
Frequently asked questions
Is Spironolactone better than Oseltamivir? ▾
Spironolactone and Oseltamivir are not "better or worse" — they treat different things. The sensible question is which fits your specific need.
Can Spironolactone and Oseltamivir be combined? ▾
Whether they can be combined depends on the indications and the interaction profile of each. If both are in a single prescription, the prescriber has weighed it; in self-medication they should never be combined.
Do they have the same side-effect profile? ▾
No — they belong to different classes and have distinct side-effect profiles. Each has its own prescribing information.
Products with Spironolactone
Products with Oseltamivir
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.